The effect of iron overload on in vitro HIV-1 infection

Journal of Clinical Virology

Volumn 31, Issue SUPPL. 1, 2004, Pages 92-98

  Traoré, Hafsatou Ndama ^a   Meyer, Debra ^a  

^a UNIVERSITY OF JOHANNESBURG   (South Africa)

Author keywords

Fe overload; HIV invectivity; Interleukin 2; Viability

Indexed keywords

CYTOKINE; DEFEROXAMINE; HEAT SHOCK PROTEIN 70; INTERLEUKIN 2; IRON; PROTEIN P21; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CELL DEATH; CELL VIABILITY; CHELATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FLOW CYTOMETRY; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IRON OVERLOAD; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; VIRUS REPLICATION;

EID: 9644268962     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.09.011     Document Type: Article

References (34)

1. S.R. Bartz, C.D. Pauza, J. Ivanyi, S. Jindal, W.J. Welch, and M. Malkovsky Are there roles for heat shock proteins in the replication of HIV and SIV? Symp NonHum Primate Models AIDS 11 1993 34 [abstract]
2. A. Björndal, H. Deng, M. Janson, J.R. Fiore, C. Colognesi, and A. Karlsson Co-receptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype J Virol 71 1997 7478 7487
3. J.R. Boelaert, J. Piette, G.A. Weinberg, C. Sappey, and E.D. Weinberg Iron and oxidative stress as a mechanism for the enhanced production of human immunodeficiency virus by alveolar macrophages from otherwise healthy cigarette smokers J Infect Dis 173 1996 1045 1046
4. J. Cinatl, M. Scholz, B. Weber, J. Cinatl, H. Rabenau, and B.H. Markus Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells Transplant Immunol 3 1995 313 320
5. S. Cunningham-Rundles, P.J. Giardina, R.W. Grady, C. Califano, P. McKenzie, and M. De Sousa Effect of transfusional iron overload on immune response J Infect Dis 182 2000 S115 S121
6. L. Dezza, M. Cazzola, M. Danova, C. Carlo-Stella, G. Bergamaschi, and S. Brugnatelli Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies Leukemia 3 1989 104 107
7. N.A. Georgiou, T. van der Bruggen, M. oudshoorn, S.L. Nottet, J.M. Marx, and van Asbeck Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin J Infect Dis 181 2000 484 490
8. Goldsby RA, Kindt TJ, Osbone BA. Immune effector mechanisms: cytokines. In: Freeman WH, editor. Kuby immunology. 4th ed.; 2000. p. 303-26.
9. V.R. Gordeuk, J.R. Delanghe, M.R. Langlois, and J.R. Boelaert Iron status and the outcome of HIV infection: an overview J Clin Virol 20 2001 111 115
10. J.M. Gutteridge Iron and oxygen: a biologically damaging mixture Acta Paediatr Scand Suppl 361 1989 78 85
11. L. He, and M.H. Fox Variation of heat shock protein 70 through the cell cycle in HL-60 cells and its relationship to apoptosis Exp Cell Res 232 1997 64 71
12. J. He, and N.R. Landau Use of a novel human immunodeficiency virus type 1 reporter virus expressing human placental alkaline phosphatase to detect an alternative viral receptor J Virol 69 1995 4587 4592
13. A.V. Hoffbrand, K. Ganeshaguru, J.W.L. Hooton, and M.H.N. Tattersall Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells Br J Haematol 33 1976 517 521 [abstract]
14. J.K. Lazdins, E. Altteri, T. Klimkait, K. Woods-Kook, M.R. Walker, and G. Gou He Lack of effect of desferrioxamine on in vitro HIV-1 replication Lancet 337 1991 795
15. F. Lori, A. Malykh, A. Cara, D. Sun, J.N. Weinstein, and J. Lisziewicz Hydroxyurea as an inhibitor of human immunodeficiency virus type 1 replication Science 266 1994 801 805
16. J.C. Martín, and J.C. Bandrés cells of the monocyte-macrophage lineage and pathogenesis of HIV-1 infection J AIDS 22 1999 413 429
17. L. Morris, T. Cilliers, H. Bredell, M. Phoswa, and D.J. Martin CCR5 is the major co-receptor used by HIV-1 subtype C isolates from patients with active tuberculosis AIDS Res Hum Retroviruses 17 2001 697 701
18. V.M. Moyo, I.T. Gangaidzo, V.R. Gordeux, C.F. Kiire, and A.P. Macphail Tuberculosis and iron overload in Africa: a review Central Afr J Med 43 1997 334 339
19. S.I. Patruta, and W.H. Hörl Iron and infection Kidney Int. 55 1999 S125 S130
20. R.J. Polson, R. Jenkins, M. Lombard, A.C. Williams, S. Roberts, and K. Nouri-Aria Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine Immunology 71 1990 176 181
21. J.D. Robertson, K. Datta, S.S. Biswal, and J.P. Kehrer Heat-shock protein 70 antisense oligomers enhance proteasome inhibitor-induced apoptosis J Biochem 344 1999 477 485
22. M. Santos, and M. de Sousa In vitro modulation of T-cell surface molecules by iron Cell Immunol 154 1994 498 506
23. C. Sappey, J.R. Boelaert, S. Legrand-Poels, C. Forceille, A. Favier, and J. Piette Iron chelation decreases NF-KB and HIV type 1 activation due to oxidative stress AIDS Res Hum Retroviruses 11 1995 1049 1061
24. A. Savarino, G.P. Pescarmona, and J.R. Boelaert Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences? Cell Biochem Funct 17 1999 279 287
25. V.A. Shatrov, J.R. Boelaert, W. Dröge, and V. Lehman Iron chelation decreases HIV-1 tat potentiated TNF-induced NF-KB activation in Jurkat cells Eur Cytokine Network 8 1997 37 43
26. E. Tabor, J.S. Epstein, I.K. Hewlett, and S.F. Lee Inhibition by desferrioxamine of in vitro replication of HIV-1 Lancet 337 1991 795
27. H.N. Traore, and D. Meyer Comparing qualitative and quantitative spectroscopic techniques for the detection of the effect of direct iron loading of mammalian cell cultures Methods Cell Sci 23 2002 175 184
28. B.S. Van Asbeck, N.A. Georgiou, T. van der Bruggen, M. Oudshoorn, H.S.L.M. Nottet, and J.J.M. Marx Anti-HIV effect of iron chelators: different mechanisms involved J Clin Virol 20 2001 141 147
29. E.E. Voest, H. Rooth, J.P. Neijt, B.S. van Asbeck, and J.J. Marx The in vitro response of human tumour cells to desferrioxamine is growth medium dependent Cell Prolif 26 1993 77 89
30. E.M. Walker, and S.M. Walker Effects of iron overload on the immune system Ann Clin Lab Sci 30 2000 354 365
31. E.D. Weinberg Iron withholding a defense against viral infections BioMetals 9 1996 393 399
32. E.D. Weinberg Iron loading and disease surveillance Emerg Infect Dis 5 1999 346 352
33. E.D. Weinberg, and G.A. Weinberg The role of iron in infection Curr Opin Infect Dis 8 1995 164 169
34. L. Zhang, C.D. Carruthers, T. He, Y. Huang, Y. Cao, and G. Wang HIV type 1 subtypes, co-receptor usage, snd CCR5 polymorphism AIDS Res Hum Retroviruses 13 1997 1357 1366